Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Thiosemicarbazones active against Clostridium difficile.

Costello C, Karpanen T, Lambert PA, Mistry P, Parker KJ, Rathbone DL, Ren J, Wheeldon L, Worthington T.

Bioorg Med Chem Lett. 2008 Mar 1;18(5):1708-11. doi: 10.1016/j.bmcl.2008.01.041. Epub 2008 Jan 18.

PMID:
18243694
2.

Palladium(II) complexes of NS donor ligands derived from steroidal thiosemicarbazones as antibacterial agents.

Asiri AM, Khan SA.

Molecules. 2010 Jul 8;15(7):4784-91. doi: 10.3390/molecules15074784.

3.

Synthesis, spectral studies and in vitro antibacterial activity of steroidal thiosemicarbazone and their palladium (Pd (II)) complexes.

Khan SA, Yusuf M.

Eur J Med Chem. 2009 May;44(5):2270-4. doi: 10.1016/j.ejmech.2008.06.008. Epub 2008 Jun 21.

PMID:
18715679
4.

Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives.

Zhang SJ, Yang Q, Xu L, Chang J, Sun X.

Bioorg Med Chem Lett. 2012 Aug 1;22(15):4942-5. doi: 10.1016/j.bmcl.2012.06.039. Epub 2012 Jun 19.

PMID:
22765891
5.

Copper complexes of imidazole-2-, pyrrole-2- and indol-3-carbaldehyde thiosemicarbazones: inhibitory activity against fungi and bacteria.

Rodríguez-Argüelles MC, López-Silva EC, Sanmartín J, Pelagatti P, Zani F.

J Inorg Biochem. 2005 Nov;99(11):2231-9. Epub 2005 Sep 26.

PMID:
16188319
6.

Discovery of a potent phenolic N1-benzylidene-pyridinecarboxamidrazone selective against Gram-positive bacteria.

Rathbone DL, Parker KJ, Coleman MD, Lambert PA, Billington DC.

Bioorg Med Chem Lett. 2006 Feb 15;16(4):879-83. Epub 2005 Nov 18.

PMID:
16298528
7.

An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues.

Maccioni E, Cardia MC, Distinto S, Bonsignore L, De Logu A.

Farmaco. 2003 Sep;58(9):951-9.

PMID:
13679191
8.

In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.

Karlowsky JA, Laing NM, Zhanel GG.

Antimicrob Agents Chemother. 2008 Nov;52(11):4163-5. doi: 10.1128/AAC.00476-08. Epub 2008 Aug 25.

9.

Synthesis and in vitro antibacterial activity of new steroidal thiosemicarbazone derivatives.

Khan SA, Kumar P, Joshi R, Iqbal PF, Saleem K.

Eur J Med Chem. 2008 Sep;43(9):2029-34. doi: 10.1016/j.ejmech.2007.12.004. Epub 2007 Dec 23.

PMID:
18450330
10.

In vitro activity of OPT-80 against Clostridium difficile.

Ackermann G, Löffler B, Adler D, Rodloff AC.

Antimicrob Agents Chemother. 2004 Jun;48(6):2280-2.

11.

Synthesis of 1H-indole-2,3-dione-3-thiosemicarbazone ribonucleosides as antibacterial agents.

Kassab SE, Hegazy GH, Eid NM, Amin KM, El-Gendy AA.

Nucleosides Nucleotides Nucleic Acids. 2010 Jan;29(1):72-80. doi: 10.1080/15257770903459267.

PMID:
20391194
12.

Synthesis, spectral characterization and eukaryotic DNA degradation of thiosemicarbazones and their platinum(IV) complexes.

Al-Hazmi GA, El-Metwally NM, El-Gammal OA, El-Asmy AA.

Spectrochim Acta A Mol Biomol Spectrosc. 2008 Jan;69(1):56-61. Epub 2007 Mar 16.

PMID:
17500028
13.

In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.

Hames A, Perry JD, Gould FK.

J Antimicrob Chemother. 2009 May;63(5):1076. doi: 10.1093/jac/dkp048. Epub 2009 Feb 24. No abstract available.

PMID:
19240074
14.

In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones.

Aguirre G, Boiani L, Cerecetto H, Fernández M, González M, Denicola A, Otero L, Gambino D, Rigol C, Olea-Azar C, Faundez M.

Bioorg Med Chem. 2004 Sep 15;12(18):4885-93.

PMID:
15336268
15.

Comparison of the E test to the reference agar dilution method for antibiotic susceptibility testing of Clostridium difficile.

Poilane I, Cruaud P, Torlotin JC, Collignon A.

Clin Microbiol Infect. 2000 Mar;6(3):155-6. No abstract available.

16.

OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review.

Gerber M, Ackermann G.

Expert Opin Investig Drugs. 2008 Apr;17(4):547-53. doi: 10.1517/13543784.17.4.547 . Review.

PMID:
18363518
17.

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.

Rea MC, Clayton E, O'Connor PM, Shanahan F, Kiely B, Ross RP, Hill C.

J Med Microbiol. 2007 Jul;56(Pt 7):940-6.

PMID:
17577060
18.

Antibiotic activity against genotypically distinct and indistinguishable Clostridium difficile isolates.

Freeman J, Wilcox MH.

J Antimicrob Chemother. 2001 Feb;47(2):244-6. No abstract available.

PMID:
11157920
19.

Synthesis and in vitro antimicrobial studies of some new 3-[phenyldiazenyl] benzaldehyde N-phenyl thiosemicarbazones.

Halve AK, Bhashkar B, Sharma V, Bhadauria R, Kankoriya A, Soni A, Tiwari K.

J Enzyme Inhib Med Chem. 2008 Feb;23(1):77-81. doi: 10.1080/14756360701408614 .

PMID:
18341257
20.

Pleuromutilin derivatives having a purine ring. Part 2: influence of the central spacer on the antibacterial activity against Gram-positive pathogens.

Hirokawa Y, Kinoshita H, Tanaka T, Nakamura T, Fujimoto K, Kashimoto S, Kojima T, Kato S.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):170-4. doi: 10.1016/j.bmcl.2008.10.123. Epub 2008 Nov 5.

PMID:
19028096

Supplemental Content

Support Center